Lymphoma Action

Idelalisib not recommended for refractory follicular lymphoma

Standard post

… people with follicular lymphoma that has not responded (refractory) to two previous courses of treatment. People who … evidence that idelalisib is effective in people with refractory follicular lymphoma. In particular, NICE felt it … recommending idelalisib for use on the NHS for people with refractory follicular lymphoma. … Idelalisib not recommended …

Lymphoma that comes back (relapses) or doesn’t respond to treatment (refractory)

Health page

… What do ‘relapsed lymphoma’ and ‘refractory lymphoma’ mean? Doctors sometimes use the terms ‘ relapse ’ and ‘ refractory ’ to describe lymphoma. Relapse Usually, doctors … about relapse and addresses some commonly asked questions. Refractory lymphoma Doctors might say that your lymphoma is …

NICE recommends ibrutinib for relapsed or refractory mantle cell lymphoma

Standard post

… mantle cell lymphoma that has relapsed (come back) or was refractory (didn’t respond) to previous treatments. Mantle … after it has been treated. People with relapsed and refractory mantle cell lymphoma have very limited treatment … quality of life benefits for people with relapsed or refractory mantle cell lymphoma. This treatment has already …

'Impressive' results of a new approach to relapsed or refractory Hodgkin lymphoma

Standard post

… lymphoma that has come back (relapsed) or not responded (refractory) after previous treatment. In this study, people with relapsed or refractory classical Hodgkin lymphoma who had had at least … already available to treat certain people with relapsed or refractory Hodgkin lymphoma. Decitabine is a chemotherapy …

New treatment approval for relapsed or refractory DLBCL

Standard post

… long-lasting responses for many people with relapsed or refractory DLBCL who were not able to have a stem cell … lenalidomide, for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who can’t … cell transplant. … New treatment approval for relapsed or refractory DLBCL …

KB-0742: A phase 1 and 2 trial of KB-0742 in people with relapsed or refractory non-Hodgkin lymphoma

Trial

… it is in patients with NHL which has relapsed or is refractory to treatment. This is a phase 1 (early phase) … over 18 with NHL which has relapsed after, or become refractory to, other treatments at least 4 weeks ago may be … which has returned after (relapsed) or not responded (is refractory ) to treatment. You can share the following …

BO43243: A phase 1 trial of mosunetuzumab in relapsed or refractory chronic lymphocytic leukaemia (CLL)

Trial

… back (relapsed) or not responded to previous treatment (refractory). This is a phase 1 (early phase) trial . Little … mosunetuzumab in people with CLL that is relapsed or refractory. You can share the following ClinicalTrials.gov … … BO43243: A phase 1 trial of mosunetuzumab in relapsed or refractory chronic lymphocytic leukaemia (CLL) …

GLOBRYTE: A phase 3 trial of glofitamab in people with relapsed or refractory mantle cell lymphoma

Trial

… given alone, in the treatment of patients with relapsed or refractory MCL. It will be compared to either: Rituximab plus … and destroy them. Who can enter People with relapsed or refractory MCL who have previously received a BTK inhibitor … (MCL) which has come after (relapsed) , or not responded (refractory) to treatment. You can share the following …

Mahogany: A phase 3 trial of zanubrutinib and anti-CD20 in people with relapsed or refractory follicular or marginal zone lymphoma

Trial

… along with monoclonal CD20 antibodies in relapsed and refractory FL and MZL. There are two aspects to the trial … on the type of lymphoma: Patients with relapsed or refractory FL will receive zanubrutinib plus obinutuzumab or … lenalidomide plus rituximab (R2) Patients with relapsed or refractory MZL will receive zanubrutinib plus lenalidomide or …

Zuma-22: A trial testing axicabtagene ciloleucel in people with relapsed or refractory follicular lymphoma

Trial

… axicabtagene ciloleucel works in patients with relapsed or refractory follicular lymphoma when compared to the standard … against current treatment in adults with relapsed or refractory follicular lymphoma. You can share the following … testing axicabtagene ciloleucel in people with relapsed or refractory follicular lymphoma …